BIOMAT Database Logo BIOMAT Database Logo

Oral idarubicin in elderly patients with acute myeloid leukemia. 1990

N Keldsen, and H Karle, and N E Hansen, and N I Nissen

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D015255 Idarubicin An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA. 4-Demethoxydaunorubicin,4-Desmethoxydaunorubicin,IMI-30,Idarubicin Hydrochloride,NSC-256439,4 Demethoxydaunorubicin,4 Desmethoxydaunorubicin,Hydrochloride, Idarubicin,IMI 30,IMI30,NSC 256439,NSC256439
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent.
February 1989, European journal of haematology,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia.
February 2003, Haematologica,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemia.
October 2013, Japanese journal of clinical oncology,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia.
January 1997, Haematologica,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patients.
January 1991, Leukemia & lymphoma,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Oral Idarubicin in Elderly Acute Leukemia and Myelodyplastic Syndromes.
January 1990, Leukemia & lymphoma,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia.
June 1994, Annals of hematology,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Idarubicin in induction treatment of acute myeloid leukemia in the elderly.
January 1997, Haematologica,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Oral idarubicin in elderly acute leukemia and refractory anemia with excess of blasts.
January 1990, Haematology and blood transfusion,
N Keldsen, and H Karle, and N E Hansen, and N I Nissen
Idarubicin including regimens in acute myelogenous leukemia in elderly patients.
September 1999, Critical reviews in oncology/hematology,
Copied contents to your clipboard!